Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9X94
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,357
Award facts
- Contract value 100% obligated
- $10,357.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) on January 15, 2026, for Mounjaro 7.5 mg/0.5 mL pens with a ceiling value of $10,357.31 and a completion date of January 16, 2026. This contract was competitively awarded with no set-aside designation. The delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 vehicle that runs through December 2031 and serves as the primary mechanism for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
The DLA Medical Supply Chain utilizes the Pharmaceutical Prime Vendor program to distribute essential medications across the Department of Defense healthcare system, including military treatment facilities and veterans' programs. This specific delivery order for Mounjaro, a diabetes medication, represents one of numerous pharmaceutical acquisitions AmerisourceBergen executes under its comprehensive IDC with DLA. The parent IDC encompasses a broad range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, positioning AmerisourceBergen as a critical vendor in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9X94?
SPE2DR26F9X94 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F9X94 worth?
The government has obligated $10,357 on SPE2DR26F9X94.
Is contract SPE2DR26F9X94 an order under another contract?
Yes. SPE2DR26F9X94 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9X94 competed?
The extent of competition for SPE2DR26F9X94 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award